Vitamin D deficiency and low bone mineral density in native Chinese rheumatoid arthritis patients

International Journal of Rheumatic Diseases

Volumn 17, Issue 1, 2014, Pages 66-70

  Chen, Juan ^a   Liu, Wen ^a   Lin, Qingyan ^a   Chen, Liying ^a   Yin, Junping ^b   Huang, Huiping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Native Chinese and rheumatoid arthritis; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ADULT; ARTICLE; BONE DENSITY; CHINESE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

NATIVE CHINESE AND RHEUMATOID ARTHRITIS; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BONE DENSITY; BONE DISEASES, METABOLIC; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; FEMUR; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; OSTEOPOROSIS; RHEUMATOID FACTOR; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84893672540     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12160     Document Type: Article

References (20)

1. Roux C (2010) Osteoporosis in inflammatory joint diseases. Osteoporos Int 22(2), 421-33.
2. Pye SR, Adams JE, Ward KA, Bunn DK, Symmons DP, O'Neill TW (2010) Disease activity and severity in early inflammatory arthritis predict hand cortical bone loss. Rheumatology (Oxford) 49(10), 1943-8.
3. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50(1), 72-7.
4. Zhang R, Naughton DP (2010) Vitamin D in health and disease: current perspectives. Nutr J 9, 65.
5. Manickam B, Washington T, Villagrana NE, Benjamin A, Kukreja S, Barengolts E (2012) Determinants of circulating 25-hydroxyvitamin D and bone mineral density in young physicians. Endocr Pract 18(2), 2192-6.
6. Zhao J, Xia W, Nie M et al. (2010) The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause 18, 1237-43.
7. Rossini M, Bagnato G, Frediani B et al. (2011) Relationship of focal erosions, bone mineral density, and parathyroid hormone in rheumatoid arthritis. J Rheumatol 38(6), 997-1002.
8. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3), 3152-4.
9. Cutolo M, Otsa K, Laas K et al. (2006) Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24, 702-4.
10. Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A (2011) Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm 86, 327-51.
11. Colin EM, Asmawidjaja PS, van Hamburg JP et al. (2010) 1, 25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62(1), 132-42.
12. Edwards CJ, Williams E (2010) The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporos Int 21(8), 1287-93.
13. Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN (2006) The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 33(12), 2398-408.
14. van Hamburg JP, Asmawidjaja PS, Davelaar N et al. (2006) TNF blockade requires 1, 25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis 71(4), 6061-2.
15. Kroger H, Penttila IM, Alhava EM (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22(4), 172-7.
16. Ardawi MS (2010) High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int 23(2), 675-86.
17. Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM (2010) Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 22(2), 463-75.
18. Ooms ME, Lips P, Roos JC et al. (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10(8), 1177-84.
19. Malavolta N, Pratelli L, Frigato M, Mule R, Mascia ML, Gnudi S (2005) The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women. Osteoporos Int 16(12), 1691-7.
20. Cantorna MT, Hayes CE, DeLuca HF (1998) 1, 25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128(1), 68-72.